We are live on
!
Find out more
Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings
AUM
$43.4B
1-Year Est. Return
51.29%
This Fund
S&P 500
This Quarter
Est. Return
+1.73%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$22.9B
AUM Growth
+$801M
(+3.6%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
5.48%
Top 10 Holdings %
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franco-Nevada
FNV
|
+$159M |
| 2 |
TC Energy
TRP
|
+$105M |
| 3 |
Marvell Technology
MRVL
|
+$92.4M |
| 4 |
Infosys
INFY
|
+$83.4M |
| 5 |
Pan American Silver
PAAS
|
+$81.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celestica
CLS
|
+$111M |
| 2 |
SAP
SAP
|
+$107M |
| 3 |
Brookfield Asset Management
BAM
|
+$98.6M |
| 4 |
Scotiabank
BNS
|
+$89M |
| 5 |
Canadian Natural Resources
CNQ
|
+$81.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 23.76% |
| 2 | Technology | 17.69% |
| 3 | Industrials | 12.67% |
| 4 | Energy | 11.54% |
| 5 | Materials | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Smart Sand
SND
$215M
| $28.2K | ﹤0.01% |
10,879
-2,833
| -21% | -$6.66K |
|
1377
Liberty Live Group Series C
LLYVK
$9.86B
| $23.8K | ﹤0.01% |
349
| – | – |
|
1378
LiveOne
LVO
$56.4M
| $16.5K | ﹤0.01% |
2,361
+2
| +0.1% | +$20 |
|
1379
TRX Gold Corp
TRX
$341M
| $16.5K | ﹤0.01% |
52,700
+4,000
| +8% | +$1.26K |
|
|
KG
1380
Kestrel Group
KG
$61.8M
| $14.1K | ﹤0.01% |
+1,238
| New | +$23.3K |
|
1381
Lineage Cell Therapeutics
LCTX
$268M
| $11.9K | ﹤0.01% |
26,393
-159,515
| -86% | -$93.6K |
|
|
THM
1382
International Tower Hill Mines
THM
$688M
| $11.2K | ﹤0.01% |
+17,500
| New | +$9.41K |
|
|
GLDG
1383
GoldMining Inc
GLDG
$223M
| $10.3K | ﹤0.01% |
+12,400
| New | +$10.1K |
|
1384
Aaon
AAON
$7.49B
| – | – |
-74,876
| Closed | -$8.81M |
|
1385
Adicet Bio
ACET
$78.1M
| – | – |
-3,198
| Closed | -$49.2K |
|
1386
Axcelis
ACLS
$4.45B
| – | – |
-33,376
| Closed | -$2.33M |
|
|
ADVM
1387
DELISTED
Adverum Biotechnologies
ADVM
| – | – |
-18,261
| Closed | -$85.3K |
|
1388
AES
AES
$10.5B
| – | – |
-445,620
| Closed | -$5.74M |
|
1389
American Financial Group
AFG
$12B
| – | – |
-2,875
| Closed | -$394K |
|
1390
Affirm
AFRM
$26B
| – | – |
-169,940
| Closed | -$10.3M |
|
1391
American International
AIG
$39.8B
| – | – |
-5,806
| Closed | -$423K |
|
1392
Albany International
AIN
$1.82B
| – | – |
-6,666
| Closed | -$533K |
|
1393
Arthur J. Gallagher & Co
AJG
$64.4B
| – | – |
-1,736
| Closed | -$493K |
|
1394
Alcon
ALC
$35.3B
| – | – |
-32,105
| Closed | -$2.73M |
|
1395
Apollo Global Management
APO
$83.2B
| – | – |
-156,514
| Closed | -$25.8M |
|
1396
Apogee Enterprises
APOG
$887M
| – | – |
-36,463
| Closed | -$2.6M |
|
1397
Atkore
ATKR
$3.17B
| – | – |
-80,352
| Closed | -$6.71M |
|
|
ATXS
1398
DELISTED
Astria Therapeutics
ATXS
| – | – |
-22,160
| Closed | -$198K |
|
1399
Aura Biosciences
AURA
$791M
| – | – |
-18,364
| Closed | -$151K |
|
1400
Avery Dennison
AVY
$13.5B
| – | – |
-12,597
| Closed | -$2.36M |
|
Similar funds
LP
HF
TI
Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review
As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.
- Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
- Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
- Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
- Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
- Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
- Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
- Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.
Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.